Background/Aims: Transforming growth factor beta 1 (TGF-β1) plays a critical role in the pathogenesis of glomerulosclerosis. The purpose of this study was to examine the effects of inhibition of transient receptor potential cation channel C6 (TRPC6) on podocyte injury induced by TGF-β1 via nephrin and desmin mechanisms. Methods: A rat model of nephropathy was first induced by intravenous injections of adriamycin to determine TRPC6 signal pathway engaged in glomerulosclerosis in vivo. Conditionally immortalized podocytes were cultured in vitro and they were divided into four groups: control; TGF-β1 treatment; TGF-β1 with TRPC6 knockdown and TGF-β1 without TRPC6 knockdown. Real time RT-PCR and Western blot analysis were employed to determine the mRNA and protein of expression of nephrin, desmin and caspase-9, respectively. Flow cytometry was used to examine the apoptotic rate of podocytes and DAPI fluorescent staining was used to determine apoptotic morphology. Results: In vivo experiment, adriamycin significantly upregulated the protein expression of TGF-β1, TRPC6, desmin and caspase-9, and decreased nephrin. Consistent with the latter results, in vitro experiment mRNA and protein expression of desmin and caspase-9 was increased in cultured TGF-β1-treated podocytes, whereas nephrin was declined as compared with the control group. Importantly, TRPC6 knockdown significantly attenuated the upregulated desmin and caspase-9, and alleviated impairment of nephrin induced by TGF-β1. Moreover, typical morphologic features were presented in apoptotic podocytes. The number of apoptotic podocytes was increased after exposure to TGF-β1 and this was alleviated after TRPC6 knockdown. TRPC6 knockdown also decreased an apoptosis rate of TGF-β1-treated podocytes. Note that negative TRPC6 transfection control failed to alter an increase of the apoptosis rate in TGF-β1-treated podocytes. Conclusions: TGF-β1 induced by glomerulosclerosis impairs the protein expression of nephrin and amplifies the protein expression of desmin and caspase -9 via TRPC6 signal pathway. Inhibition of TRPC6 alleviates these changes in podocytes-treated with TGF-β1 and attenuated apoptosis of podocytes.
Introduction
Transforming growth factor beta 1 (TGF-β1) is a polypeptide member of the transforming growth factor beta superfamily of cytokines [1, 2] . It is a secreted protein that performs many cellular functions including the control of cell growth, proliferation and differentiation; and dysregulation of TGF-β activation and signaling results in cell apoptosis. [3] [4] [5] . Notably, TGF-β1 is one of important cytokines in renal tissues in contribution to the pathogenesis of glomerulosclerosis [6] . Overexpression of TGF-β1 has been revealed in kidney diseases of human and animal models and TGF-β1 produced in glomerulus plays a role in regulating multiple pathophysiological functions in the process of the diseases [6] [7] [8] . For instance, TGF-β1 stimulates expansion of extracellular matrix (ECM) and exacerbates podocyte injury including changes of cell morphology, detachment from glomerular basement membrane and apoptosis [9, 10] . Prior studies have further demonstrated a number of intracellular signal pathways [i.e., mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK), phosphatidyl inositol-3-kinase (PI3K) and nuclear factor-κB (NF-κB) etc.] in involvement of podocyte injury induced by TGF-β1 [11] [12] [13] .
Transient receptor potential cation ion channel C6 (TRPC6) is a multiple transmembrane protein and mediates the release of cytosolic compartmentalized calcium [14, 15] . It is activated by mechanical stimuli such as membrane stretch and/or by diacylglycerol via phospholipase C mechanisms [16] . The Src kinase Fyn also increases TRPC6 channel conductivity [17] . It should be noted that TRPC6 is localized in podocyte and mutated in patients who have a subset of autosomal dominant focal segmental glomerulosclerosis (FSGS) [15, 18, 19] . Prior studies have also shown that mutated TRPC6 increases the cytosolic calcium signals [18, 20] . Nonetheless, the precise mechanisms by which TRPC6 mediates glomerular podocyte injuries induced by TGF-β1 remain to be determined. Thus, the purpose of this study was to determine engagement of nephrin and desmin in TRPC6 modulating podocyte injury induced by TGF-β1. First, we induced nephropathy (an analogue of human FSGS) in rats by intravenous injections of adriamycin (ADR) [21] and further examined the protein expression of TGF-β1, TRPC6, nephrin, desmin and caspase-9 in glomerulosclerosis in vivo. Second, we performed in vitro experiments to determine the effects of TRPC6 knockdown on TGF-β1-induced podocyte apoptosis. We hypothesized that ADR upregulates TGF-β1 and TRPC6 and thereby impairing the protein expression of nephrin and exaggerating expression of desmin and caspase -9. We further hypothesized that nephrin and desmin mechanisms are involved in apoptosis of podocyte caused by heightened TGF-β1. We also hypothesized that knockdown of TRPC6 attenuates podocyte apoptosis induced by TGF-β1 and alleviates the abnormalities in nephrin and desmin.
Materials and Methods

Animals
All experimental procedures were in accordance with the guidelines of the International Association for the Study of Pain and were approved by the Animal Research Committee of Youjiang Medical University for Nationalities. Male Sprague-Dawley rats weighing 200-250 g were used in this study. A rat model of nephropathy was induced by intravenous injections of ADR (4 mg/kg at the first week and 2 mg/kg at the fourth week) after the right kidney was extirpated as described previously [22] . Age-and body weight-matched rats with sham-operation and saline injection were used as controls. Urine samples were collected before the surgery and at the end of each week. Then, urinary protein concentrations were determined by colorimetric assay (Bio-Rad) using bovine serum albumin (BSA) as the standard. Proteinuria was confirmed by urinary protein concentrations in samples. At the end of the sixth week rats were sacrificed and the kidney was removed for the Western blot analysis to determine the protein expression of TGF-β1, TRPC6, nephrin, desmin and caspase-9.
Podocyte culture and treatment
Conditionally immortalized mouse podocyte cells were maintained at 33°C for proliferation in RPMI 1640 containing 10% fetal bovine serum (Gibco) and 10U/ml of recombinant mouse γ-interferon (Invitrogen). They were then moved to 37°C for differentiation and cultured without γ-interferon. When they grew to about 80% confluence, podocytes were treated with 6 ng/ml of TGF-β1 (Invitrogen) in serumfree medium and incubated with the PGPU6/GFP/Neo-TRPC6-mus-581 and PGPU6/GFP/Neo-NC according to the manufacture's protocol. Then, they were moved to 37°C and treated with 6 ng/ml of TGF-β1 for 48 hours. Thus, the cultured podocytes were divided as control; TGF-β1-treatment; TGF-β1-treatment with PGPU6/GFP/Neo-TRPC6-mus-581 and TGF-β1-treatment with PGPU6/GFP/Neo-NC.
Real-time PCR
RT-PCR was performed using the TaqmanW Universal PCR Master Mix (Applied Biosys.). This mix contains AmpliTaq GoldW DNA Polymerase, AmpEraseW UNG, ROX passive reference, buffer and dNTPs, as well as gene-specific primers for the mRNA amplification of the following genes: nephrin, desmin and caspase -9. In addition, 18 s rRNA (TaqmanW PDAR) was used as an endogenous control to correct for variations in the samples. RT-PCR was performed in duplicate in 96-well plates containing 2 μL of cDNA. The thermal conditions of the cycles were 50°C for 2 minutes, 60°C for 30 minutes, and 95°C for 5 minutes and this was followed by 40 cycles at 94°C for 20 seconds and 62°C for 60 seconds. The data were collected in the ABI PRISM SDS 7000 thermal cycler. Relative quantification of target gene expression was performed using the 2 -ΔΔCt comparative method and the threshold cycle value was defined by the point at which there was a statistically significant detectable increase in fluorescence.
Western blot
Total protein in tissue and cells was extracted by homogenizing sample in ice-cold radioimmunoprecipitation assay buffer with protease inhibitor cocktail kit (Roche). The lysates were centrifuged and the supernatants were collected for measurements of protein concentrations using a bicinchoninic acid assay reagent kit. Fifty microgram of total protein was loaded to run 7.5% or 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the protein was transferred to nitrocellulose membranes (GE Healthcare Biosci). Then, the membranes were incubated for 30 minutes in 5% low-fat milk prepared with Tris-buffered saline containing 0.05% Tween-20 (TTBS). Subsequently, the membranes were incubated with primary antibodies as the rabbit anti-TGF-β1, anti-TRPC6, anti-nephrin, anti-desmin and anti-caspase-9 (1:200-1:500, obtained from Neuromics and Abcam Co). After being fully washed, the membrane was incubated with horseradish peroxidase-linked anti-rabbit secondary antibody (1:250) and visualized for immunoreactivity. The membrane was also processed to detect β-actin or GAPDH for equal loading. The bands recognized by the primary antibody were visualized and the optical densities of protein bands were analyzed using the ImageJ software.
Determination of apoptosis in cultured podocytes
Annexin V-FITC Apoptosis Detection Kit (BD Biosciences) was applied to evaluate podocyte injury. Briefly, podocytes were harvested and washed twice with pre-cold phosphate-buffered saline (PBS). 1 x 10 6 cells were re-suspended in 1 µg/ml FITC-Annexin V for 30 min at 4°C followed by adding 5 µl of 50 µg/ml propidium iodide immediately prior to detection with flow cytometry (FACScan). Cells that stained positive for FITC Annexin V and negative for propidium iodide were considered as undergoing apoptosis. Cells were characterized as viable, necrotic, early apoptotic or late apoptotic according to standard staining characteristics. The apoptosis rate was measured as the fraction of cells in early and late apoptosis. The measurement was repeated 3 times for each group and the mean value was obtained by averaging these data to indicate apoptosis rate. In addition, DAPI fluorescent staining was also used to assess apoptosis of podocytes. In this approach, podocytes were cultured and treated for 72 hours and then 10 µg/ml of DAPI in PBS was added at 37°C for 15 min. DAPI-positive cells were observed using a fluorescence microscope and images were taken.
Statistical analysis
All data were analyzed using a two-way repeated-measures analysis of variance. Values were presented as means ± standard error of mean (SEM). For all analyses, differences were considered significant at P < 0.05. All statistical analyses were performed by using SPSS for Windows version 17.0 (SPSS, USA).
Results
In vivo experiments using a rat model of ADR nephropathy (ADRN)
In order to study the role of TRPC6 in the pathophysiological processes of ADRN, we first examined the protein expressions of TGF-β1, TRPC6, nephrin, desmin and caspase-9 in situ renal tissues of the ADRN rat model. Figure 1(a) shows that the levels of urinary protein began to significantly increase 2 weeks after ADR injection and reached to a higher level at the sixth week. Then, the protein levels of TGF-β1, TRPC6, nephrin, desmin and caspase-9 were determined in control rats and ADRN rats with 6 weeks of ADR injection. Figure 1(b) shows that TGF-β1, TRPC6, desmin and caspase-9 were upregulated in ADRN rats (P < 0.05 vs. control rats for all the proteins) whereas nephrin was decreased in ADRN rats (P < 0.05 vs. control rats) as compared with control animals.
Effectiveness in vitro experiments
As demonstrated in Fig. 2(a) , we first observed that the cultured podocyte appeared in a typical shape and a specific marker nephrin was contained in the cultured podocyte used in our experiments. Also, nephrin was identified by using the PCR method. Figure 2 (b) shows that expression of GFP on podocytes was increased 24 and 48 hours following transfection and it appeared slightly greater in 48 hours post-transfection than that in 24 hours post-transfection. In addition, Fig. 2(c) shows that downregulation of protein expression of TRPC6 was observed in podocytes in which PGPU6/GFP/Neo-TRPC6-mus-581 was transfected as compared with the control group and negative transfection group (P < 0.05). 
Fig. 3. (a)
The expression of mRNA of desmin and caspase-9 was increased in cultured TGF-β1-treated podocytes, whereas mRNA of nephrin was decreased. TRPC6 knockdown significantly restored these changes. * P < 0.05 vs. β1-treated podocytes without TRPC6 knockdown and β1-treated podocytes with negative control. (b) Averaged data and typical bands showing the protein levels of desmin and caspase-9 expression were increased in cultured TGF-β1-treated podocytes and nephrin was decreased. As TRPC6 was knocked down these changes were blunted. * P < 0.05 vs. β1-treated podocytes without TRPC6 knockdown and β1-treated podocytes with negative control. # P < 0.05 vs. β1-treated podocytes without TRPC6 knockdown and β1-treated podocytes with negative control.
TRPC6 observed in podocytes with transfection of PGPU6/GFP/Neo-TRPC6-mus-581. * P < 0.05 vs. control group and negative transfection group. Figure 3 shows that as compared with the control group, mRNA and protein expression of desmin and caspase-9 was increased in cultured TGF-β1-treated podocytes (P < 0.05), whereas mRNA and protein expression of nephrin was decreased (P < 0.05). In addition, TRPC6 knockdown significantly attenuated amplifications in desmin and caspase-9 as well as a reduction in nephrin induced by 48 hours of TGF-β1 treatment. Figure 4 (a & b) illustrate that TRPC6 knockdown decreased the apoptosis rate of TGF-β1-treated podocytes (10 ± 1% after TRPC6 knockdown vs. 14 ± 2% without knockdown, P < 0.05). Note that negative transfection control failed to alter an increase of apoptosis rate in TGF-β1-treated podocytes. Moreover, Figure 4 (c & d) illustrate that typical morphologic features were presented in apoptotic podocytes. This figure also shows that the number of apoptotic podocytes was increased after exposure to TGF-β1 for 48 hours and this was attenuated after TRPC6 knockdown.
Effects of TRPC6 knockdown on expression of nephrin, desmin and caspase-9
Effects of TRPC6 knockdown on apoptosis of podocyte
Discussion
ADR-induced nephropathy model has been considered as an analogue of human FSGS [21] . Prior studies suggest that TGF-β1/Smad signaling activity plays a key role in the accumulation of ECM in ADRN [23] . In the present study using the same rat model, our results demonstrated that the protein expression of TGF-β1, TRPC6, desmin and caspase-9 are upregulated, whereas nephrin is decreased in ADRN rats. Consistently, we observed the same changes of desmin, caspase-9 and nephrin in the cultured podocytes transfected with TGF-β1. Considering that there are limitations for application of TRPC6 antagonist in vivo experiment and its specificity, we performed a series of in vitro experiments in order to determine the role played by TRPC6 in mediating TGF-β1-induced podocyte injury. Our data showed that TRPC6 knockdown significantly alleviates impaired nephrin and attenuates amplifications in desmin and caspase-9 observed in podocytes treated with TGF-β1. Moreover, TRPC6 knockdown decreases an apoptosis rate of TGF-β1-treated podocytes. Overall, our data suggest that molecular mediators such as desmin, caspase-9 and nephrin are engaged in the role of TRPC6 signal in mediating podocyte injury induced by TGF-β1.
In general, podocytes are the target of injury in chronic glomerular diseases. In these diseases, TGF-β1 is secreted by mesangial cells and stored in ECM as latent complexes, and then transported to podocyte surface [24] . On podocytes, TGF-β1 binds to its receptor and activate its downstream signaling pathways including Smad, MAPK, ERK and PI3K to modulate the expression of its target genes [7, 11, 13] . TGF-β1 protein increases in these podocytes with the cellular lesions of FSGS [7, 8] . It has been reported that TGF-β1 reduces podocyte adhesion through α3β1 integrin downregulation and thus induces podocyte apoptosis [25] .
In addition, podocytes undergo apoptosis at early stages in the course of progressive glomerulosclerosis in TGF-β1 transgenic mice [26, 27] . A prior study has demonstrated that local production of TGF-β1 leads to the progression of podocyte damage [11] . In the cultured murine podocytes, it was also reported that TGF-β1 induces podocyte apoptosis [28] . Interestingly, TRPC6 is induced in TGF-β1-treated podocyte, implying that TRPC6 is likely involved in TGF-β1-induced podocyte injury. In podocytes, it has been reported that the cytosolic free Ca2+ level is strongly regulated by TRPC6, which can be activated by the exogenous application of diacylglycerol. The enhanced cytosolic Ca2+ activates the Ca2+ dependent phosphatase calcineurin linked to the induction of apoptosis [19, 29] . Therefore, TGF-β1 is likely to affect TRPC6 channel activity in podocyte. Our present study found that TRPC6 knockdown attenuates the apoptosis rate in TGF-β1-treated podocyte, which also is linked to impaired nephrin and upregulated desmin and caspase-9. These data suggest that these molecular protein mediators are necessary in involvement of TRPC6 signal engaged in podocyte damage induced by TGF-β.
Nephrin is a transmembrane protein that is a structural component of the slit diaphragm and necessary for the proper functioning of the renal filtration barrier [30] [31] [32] . The renal filtration barrier consists of fenestrated endothelial cells, the glomerular basement membrane, and the podocytes of epithelial cells [30] [31] [32] . They are present on the tips of the podocytes and maintain the normal relationship between the basement membrane and the podocytes of the epithelial cells. Nephrin regulates a number of pathways in the podocyte, suppresses cell death and apparently forms a complex with podocin [30] . Thus, depletion of nephrin and podocin is associated with degradation of the foot process [30] . A defect in the gene for nephrin, NPHS1, is associated with congenital nephrotic syndrome of the Finnish type and causes massive amounts of protein to be leaked into the urine or proteinuria [33] . Nephrin has also been used as a biomarker for kidney diseases [34] . Many factors inducing podocyte injury increase the levels of nephrin and direct evidence further shows that nephrin is very important in improving podocyte apoptosis of nephropathy including ADRN [35] [36] [37] [38] . In our present study, we found that nephrin is impaired in ADRN rats and TGF-β1-treated cultured podocytes. Inhibition of TRPC6 signal can restore the expression levels of its protein, indicating the crucial role played by TRPC6 in mediating podocyte injury induced by TGF-β1 observed in ADRN.
Desmin is a type III intermediate filament that integrates the sarcolemma, Z disk and nuclear membrane in sarcomeresand regulates sarcomere architecture [39] . In adult muscle, desmin forms a scaffold around the Z-disk of the sarcomere and connects the Z-disk to the subsarcolemmal cytoskeleton [40] . It links to the myofibrils laterally by connecting the Z-disks [39] . Through its connection to the sarcomere, desmin connects the contractile apparatus to the cell nucleus, mitochondria, and post-synaptic areas of motor endplates [39] . These connections maintain the structural and mechanical integrity of the cell during contraction while they also help in force transmission and longitudinal load bearing [40, 41] . Upregulated desmin expression is a defense mechanism in maintaining normal sarcomere alignment amidst disease pathogenesis [42] . There is evidence that desmin also connects the sarcomere to the ECM through desmosomes which is likely important in signaling between the ECM and the sarcomere in regulating tissue contraction and movement [41] . Of note, prior studies suggest that desmin is a sensitive marker of podocyte injury [43] . Also, desmin mRNA and protein are increased in cultured mouse podocytes and in vivo study it has been reported that desmin is increased in damaged mouse podocytes by insults of numerous kidney disorders, suggesting that desmin is involved in podocyte injury [44, 45] . Moreover, recovering protein levels of desmin expression play a protective role in regulating injured podocytes [46] [47] [48] . Consistent with this notion, in the current study we found that desmin is exaggerated in ADRN rats and TGF-β1-treated cultured podocytes and inhibition of TRPC6 alleviates exacerbated expression of desmin.
Conclusions
In ADRN, TGF-β1, TRPC6 and caspase-9 are upregulated and this is likely to lead to apoptosis of podocyte. Also, this process impairs the protein expression of nephrin and amplifies expression of desmin. Knockdown of TRPC6 alleviates these changes in podocytes. The data suggest that TRPC6 plays an important role in mediating podocyte injury induced by TGF-β1 and nephrin and desimin are necessary to be engaged in the role of TRPC6. Results of the current study also indicate that inhibition of TRPC6 signal pathways has a protective effect on podocyte injury. Targeting one or more of these signaling molecules may present new opportunities for treatment and management of podocyte injury observed in glomerulosclerosis.
